Gene therapy of arthritis


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Gene therapy can offer a new approach to arthritis treatment which acts at an inflammation site. Numerous studies show high efficacy of gene therapy in different models of arthritis in humans. Even a single injection of a recombinant vector results in a stable prolonged expression of a therapeutic gene and a longterm therapeutic effect. In contrast to biologic therapy involving numerous systemic injections of recombinant anti-inflammatory proteins, gene therapy does not produce systemic side effects. Vectors based on retroviruses, adenoviruses, adeno-associated viruses, and recombinant plasmids could provide delivery of target genes. Of significant importance is the development of noninvasive methods of gene therapy: intranasal and peroral. The current state of research in arthritis gene therapy is discussed in this review.

作者简介

T. Nepomnyashchikh

State Research Center of Virusology and Biotechnology “Vector”

Email: snshchel@vector.nsc.ru
俄罗斯联邦, Novosibirsk, Koltsovo, 630559

D. Antonets

State Research Center of Virusology and Biotechnology “Vector”

Email: snshchel@vector.nsc.ru
俄罗斯联邦, Novosibirsk, Koltsovo, 630559

S. Shchelkunov

State Research Center of Virusology and Biotechnology “Vector”

编辑信件的主要联系方式.
Email: snshchel@vector.nsc.ru
俄罗斯联邦, Novosibirsk, Koltsovo, 630559

补充文件

附件文件
动作
1. JATS XML

版权所有 © Pleiades Publishing, Inc., 2016